-
1
-
-
0014082977
-
Parkinsonism: Onset, progression and mortality
-
Hoehn N. M., Yahr M. D. Parkinsonism: onset, progression and mortality. Neurology: 1967; 17 427 442
-
(1967)
Neurology
, vol.17
, pp. 427-442
-
-
Hoehn, N.M.1
Yahr, M.D.2
-
2
-
-
0037105035
-
The effects of mirtazapine on sleep: A placebo controlled, double-blind study in young healthy volunteers
-
Aslan S., Isik E., Cosar B. The effects of mirtazapine on sleep: a placebo controlled, double-blind study in young healthy volunteers. Sleep: 2002; 25 677 679 (Pubitemid 34977508)
-
(2002)
Sleep
, vol.25
, Issue.6
, pp. 677-679
-
-
Aslan, S.1
Isik, E.2
Cosar, B.3
-
3
-
-
84861652848
-
Increased levels of 5-HT1A receptor binding in ventral visual pathways in Parkinson's disease
-
Huot P., Johnston T. H., Visanji N. P. et al. Increased levels of 5-HT1A receptor binding in ventral visual pathways in Parkinson's disease. Mov Disord: 2012; 27 735 742
-
(2012)
Mov Disord
, vol.27
, pp. 735-742
-
-
Huot, P.1
Johnston, T.H.2
Visanji, N.P.3
-
4
-
-
0036125178
-
2C receptors in the control of brain dopaminergic function
-
DOI 10.1016/S0091-3057(01)00705-5, PII S0091305701007055
-
Matteo V., di Cacchio M., Di Giulio C. et al. Role of serotonin (2C) receptors in the control of brain dopaminergic function. Pharmacol Biochem Behav: 2002; 71 727 734 (Pubitemid 34219223)
-
(2002)
Pharmacology Biochemistry and Behavior
, vol.71
, Issue.4
, pp. 727-734
-
-
Di Matteo, V.1
Cacchio, M.2
Di Giulio, C.3
Esposito, E.4
-
5
-
-
84961395178
-
A case in which mirtazapine reduced auditory hallucinations in a patient with Parkinson disease
-
Nagata T., Shinagawa S., Tagai K. et al. A case in which mirtazapine reduced auditory hallucinations in a patient with Parkinson disease. Int Psychogeriatr: 2012; 30 1 3
-
(2012)
Int Psychogeriatr
, vol.30
, pp. 1-3
-
-
Nagata, T.1
Shinagawa, S.2
Tagai, K.3
-
6
-
-
0031467188
-
Psychosis during chronic levodopa therapy triggered by the new antidepressive drug mirtazapine
-
Normann C., Hesslinger B., Frauenknecht S. et al. Psychosis during chronic levodopa therapy triggered by the new antidepressive drug mirtazapine. Pharmacopsychiatry: 1997; 30 263 265 (Pubitemid 28006079)
-
(1997)
Pharmacopsychiatry
, vol.30
, Issue.6
, pp. 263-265
-
-
Normann, C.1
Hesslinger, B.2
Frauenknecht, S.3
Berger, M.4
Walden, J.5
-
7
-
-
84884237905
-
Parkinson disease psychosis: Update
-
Friedman J. H. Parkinson disease psychosis: Update. Behav Neurol: 2013; 27 469 477
-
(2013)
Behav Neurol
, vol.27
, pp. 469-477
-
-
Friedman, J.H.1
-
8
-
-
69549111221
-
Management of non-motor complications in Parkinson's disease
-
Fujimoto K. Management of non-motor complications in Parkinson's disease. J Neurol: 2009; 256 03 299 305
-
(2009)
J Neurol
, vol.256
, Issue.3
, pp. 299-305
-
-
Fujimoto, K.1
-
9
-
-
0028899702
-
Mianserin treatment of patients with psychosis induced by antiparkinsonian drugs
-
Ikeguchi K., Kuroda A. Mianserin treatment of patients with psychosis induced by antiparkinsonian drugs. Eur Arch Psychiatry Clin Neurosci: 1995; 244 320 324
-
(1995)
Eur Arch Psychiatry Clin Neurosci
, vol.244
, pp. 320-324
-
-
Ikeguchi, K.1
Kuroda, A.2
-
10
-
-
0042161639
-
Inhibiteurs de la recapture de la sérotonine dans la dépression de la maladie d'Alzheimer et autres démences
-
Lebert F. Serotonin reuptake inhibitors in depression of 'Alzheimer's disease and other dementias. [Article in French] Presse Med: 2003; 32 1181 1186 (Pubitemid 36987898)
-
(2003)
Presse Medicale
, vol.32
, Issue.25
, pp. 1181-1186
-
-
Lebert, F.1
-
11
-
-
0032885118
-
Dementia with Lewy bodies: Review and pharmacotherapeutic implications
-
DOI 10.1592/phco.19.10.795.31555
-
Rojas-Fernandez C. H., MacKnight C. Dementia with Lewy bodies: review and pharmacotherapeutic implications. Pharmacotherapy: 1999; 19 795 803 (Pubitemid 29415834)
-
(1999)
Pharmacotherapy
, vol.19
, Issue.7
, pp. 795-803
-
-
Rojas-Fernandez, C.H.1
MacKnight, C.2
-
12
-
-
0030939443
-
Drug treatment in Lewy body dementia
-
Geroldi C., Frisoni G. B., Bianchetti A. et al. Drug treatment in Lewy body dementia. Dement Geriatr Cogn Disord: 1997; 8 188 197 (Pubitemid 27183225)
-
(1997)
Dementia and Geriatric Cognitive Disorders
, vol.8
, Issue.3
, pp. 188-197
-
-
Geroldi, C.1
-
13
-
-
28544442286
-
-
Neuroscientific Basis and Practical Applications Cambridge University Press
-
Stahl S. M. Stahl's Essential Psychopharmacology. Neuroscientific Basis and Practical Applications. Cambridge University Press: 2011
-
(2011)
Stahl's Essential Psychopharmacology
-
-
Stahl, S.M.1
-
14
-
-
0036898955
-
Mirtazapine in Parkinsonian tremor
-
DOI 10.1016/S1353-8020(02)00011-1, PII S1353802002000111
-
Gordon P. H., Pullman S. L., Louis E. D. et al. Mirtazapine in Parkinsonian tremor. Parkinsonism Relat Disord: 2002; 9 125 126 (Pubitemid 35447541)
-
(2002)
Parkinsonism and Related Disorders
, vol.9
, Issue.2
, pp. 125-126
-
-
Gordon, P.H.1
Pullman, S.L.2
Louis, E.D.3
Frucht, S.J.4
Fahn, S.5
-
15
-
-
0038485934
-
Mirtazapine in essential tremor: A double-blind, placebo-controlled pilot study
-
DOI 10.1002/mds.10371
-
Pahwa R., Lyons K. E. Mirtazapine in essential tremor: a double-blind, placebo-controlled pilot study. Mov Disord: 2003; 18 584 587 (Pubitemid 36656544)
-
(2003)
Movement Disorders
, vol.18
, Issue.5
, pp. 584-587
-
-
Pahwa, R.1
Lyons, K.E.2
-
16
-
-
33646020370
-
Mirtazapine in the treatment of essential tremor: An open-label, observer-blind study
-
Uccellini D., Grampa G., Spina I. et al. Mirtazapine in the treatment of essential tremor: an open-label, observer-blind study. Neuropsychiatric Disease and Treatment: 2006; 95 100
-
(2006)
Neuropsychiatric Disease and Treatment
, pp. 95-100
-
-
Uccellini, D.1
Grampa, G.2
Spina, I.3
-
17
-
-
0033595471
-
Mirtazapine treats resting tremor, essential tremor, and levodopa- induced dyskinesias
-
Pact V., Giduz T. Mirtazapine treats resting tremor, essential tremor, and levodopa-induced dyskinesias. Neurology: 1999; 53 1154 (Pubitemid 29442147)
-
(1999)
Neurology
, vol.53
, Issue.5
, pp. 1154
-
-
Pact, V.1
Giduz, T.2
-
18
-
-
0141705744
-
Does nefazodone improve both depression and Parkinson disease? A pilot randomized trial
-
DOI 10.1097/01.jcp.0000088908.24613.db
-
Avila A., Cardona X., Martin-Baranera M. et al. Does nefazodone improve both depression and Parkinson disease? A pilot randomized trial. J Clin Psychopharmacol: 2003; 23 509 513 (Pubitemid 37128680)
-
(2003)
Journal of Clinical Psychopharmacology
, vol.23
, Issue.5
, pp. 509-513
-
-
Avila, A.1
Cardona, X.2
Martin-Baranera, M.3
Maho, P.4
Sastre, F.5
Bello, J.6
|